My After Plan

Product NDC
51660-098
11-digit product format
516600098
Labeler code
51660
Product ID
51660-098_5baed416-d001-7834-e063-6394a90a0966
Type
HUMAN OTC DRUG
Nonproprietary name
levonorgestrel
Dosage form
TABLET
Route
ORAL
Labeler
OHM LABORATORIES INC
Application
ANDA207660
Marketing category
ANDA
Marketing start
2026-09-01
Substance
LEVONORGESTREL
Active strength
1.5 mg/1
Pharmacologic classes
Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A207660-001LEVONORGESTRELLEVONORGESTREL1.5MGTABLET / ORAL2019-05-02

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-0284e616aacf4f…
2026-08-18 06:07:402026-07A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-0231067a03dcf5…
2025-08-23 18:47 UTC2025-08A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-026a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-0203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-022680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-025bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-0279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-021e350fbaab3a…
2024-05-31 18:47 UTC2024-05A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-028072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-025c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-025d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-024b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-0274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-0287673890dc5c…
2021-03-12 10:30 UTC2021-03A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-025aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-028869cabd3fbd…
2020-11-12 02:37 UTC2020-11A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02c0c555d07b60…
2019-12-14 00:12 UTC2019-12A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-023f01610625f2…
2019-09-15 20:21 UTC2019-09A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02b00525d2431f…
2019-07-19 19:46 UTC2019-07A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-026a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-021c564ffb4f44…
2023-12-20 04:57 UTC2023-12A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-029b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-023f0d92c62455…
2023-05-13 08:27 UTC2023-05A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02053a50430f4f…
2023-01-26 05:58 UTC2023-01A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-023bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-023a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A207660-001LEVONORGESTREL1.5MGTABLET / ORAL2019-05-02f41ea6bd6efb…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
My After Plan
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LEVONORGESTREL1.5 mg/1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
My ChoiceLEVONORGESTRELOHM LABORATORIES INC500d9418-69a8-f4f3-e063-6394a90a9b662026-04-22WarningsExact identifier
application applno (ANDA): 207660
application number: ANDA207660
RestartLEVONORGESTRELWinx Health Inc.0cdf198e-c114-b9fa-e063-6294a90a566a2026-02-24WarningsExact identifier
application applno (ANDA): 207660
application number: ANDA207660
JulieLEVONORGESTRELJulie Products Inc2e9784da-2186-a630-e063-6294a90a84932025-07-14WarningsExact identifier
application applno (ANDA): 207660
application number: ANDA207660
Morning After PillLEVONORGESTRELCadence Health Inc2fb59f53-d885-9d4a-e063-6394a90a88cc2025-04-15WarningsExact identifier
application applno (ANDA): 207660
application number: ANDA207660
LevonorgestrelLEVONORGESTRELNaari Pte Limitedbe8b7ace-9af8-4417-85fa-863e190728872023-03-16WarningsExact identifier
application applno (ANDA): 207660
application number: ANDA207660

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
51660-098-11516600098111 BLISTER PACK in 1 CARTON (51660-098-11) / 1 TABLET in 1 BLISTER PACK1 blister pack2026-09-01NoNoCurrent